Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Atherosclerosis
|
January 28, 2021
Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
Marta Futema, Uma Ramaswami, Lukas Tichy, et al.
European Heart Journal
|
April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
European Heart Journal
|
May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Clinical Chemistry
|
May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Journal of Medical Genetics
|
July 3, 2014
Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
Marta Futema, Vincent Plagnol, KaWah Li, et al.
Atherosclerosis
|
January 29, 2014
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
Helena Gylling, Jogchum Plat, Stephen Turley, et al.
Clinical Chemistry
|
May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R Langlois, M John Chapman, Christa Cobbaert, et al.
Atherosclerosis
|
July 19, 2011
Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization
O S Descamps, S Tenoutasse, X Stephenne, et al.
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A Hegele, Henry N Ginsberg, M John Chapman, et al.
Atherosclerosis
|
October 2, 2018
A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)
Olivier S Descamps, Olivier Van Caenegem, Michel P Hermans, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Atherosclerosis
|
January 28, 2021
Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
Marta Futema, Uma Ramaswami, Lukas Tichy, et al.
European Heart Journal
|
April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
European Heart Journal
|
May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Clinical Chemistry
|
May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Journal of Medical Genetics
|
July 3, 2014
Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
Marta Futema, Vincent Plagnol, KaWah Li, et al.
Atherosclerosis
|
January 29, 2014
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
Helena Gylling, Jogchum Plat, Stephen Turley, et al.
Clinical Chemistry
|
May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R Langlois, M John Chapman, Christa Cobbaert, et al.
Atherosclerosis
|
July 19, 2011
Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization
O S Descamps, S Tenoutasse, X Stephenne, et al.
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A Hegele, Henry N Ginsberg, M John Chapman, et al.
Atherosclerosis
|
October 2, 2018
A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)
Olivier S Descamps, Olivier Van Caenegem, Michel P Hermans, et al.
Page
of 10